Novavax has reported a net loss of $7.22m, or $0.05 per share, for the third quarter ended 30 September 2012 compared to a net loss of $3.21m, or $0.03 per share, for the third quarter ended 30 September 2011. Revenue for third quarter of ...
Tags: Novavax, Wider Q3 Net Loss, net loss, clinical trials
Immunovaccine has reported a net loss of $1.7m for the third quarter ended 30 September 2012 compared to a net loss of $1.5m for the same quarter in 2011. According to the company the increased loss is due to the $155,000 increase in ...
Tags: Net Loss, therapeutic cancer vaccine, immune enhancement technology
Astellas Pharma's Gonax drug used in the treatment of prostate cancer, has been awarded marketing rights in Japan. Based on the positive results from phase I, II studies in Japan and phase III studies in abroad, Astellas has applied for ...
AFCell Medical has reported positive results of its amnion based allograft membrane, AmnioClear wound covering, designed for reducing post-operative adhesions and pain during the repair of peroneal and posterior tibial tendons. AmnioClear ...
Tags: allograft membrane, post-operative adhesions, native human amnion
Sphere Medical has presented positive results of its in-vitro diagnostic medical device designed for measuring intravenous anaesthetic propofol at the point of care. The device, Pelorus 1500, provides real time measurements of propofol ...
Tags: Sphere Medical, medical device
Two of the leading jewellers in the U.S. posted solid growth Tuesday as the economy is beginning show actual long-term positive gains, even though it is still much too sluggish. The reports indicate that heading into the all-important ...
The Board of Directors of Salvatore Ferragamo S.p.A.,parent company of the Salvatore Ferragamo Group,one of the global leaders in the luxury sector,meeting under the chairmanship of Ferruccio Ferragamo,examined and approved the Consolidated ...
Tags: Salvatore Ferragamo S.p.A, Salvatore Ferragamo Group, luxury sector
Delhaize booked a decline in third-quarter earnings,which were hit by spending on pricing in Belgium and the US. The company announced today(7 November)that operating profit fell by 3%in the three months to the end of September,dropping ...
Tags: currency exchange, margins, tough market, price competitiveness
Harris Teeter Supermarkets,Inc.(NYSE:HTSI)(the"Company")today reported that sales for the 52 weeks ended October 2,2012 increased by 5.8%to$4.54 billion from$4.29 billion in fiscal 2011.Sales for the fourth quarter of fiscal 2012 increased ...
Tags: Harris Teeter, Supermarkets, profits, acquisition
Allegro Diagnostics has presented positive results from a clinical trial of its BronchoGen genomic test, designed for the early detection of lung cancer in current and former smokers. Using the company's PCR molecular testing platform ...
Tags: clinical trial, genomic test, Lung Cancer Detection Assay
Nicox has announced the US launch of its rapid point-of-care diagnostic test, designed for the detection of acute conjunctivitis. The FDA-cleared and CLIA-waived assay, AdenoPlus, uses its four-step process to detect adenovirus and ...
Tags: rapid point-of-care diagnostic test, FDA, medical devices
NinePoint Medical has reported positive data of its NvisionVLE imaging system, designed to view real-time volumetric images of Barrett's esophagus and tissues up to 3mm deep at better than 10 micron resolution. Two single-arm, open-label ...
Tags: NvisionVLE imaging system, NvisionVLE system, Medical devices
,the multi-channel retailer,announces its Half Year results for the 26 weeks ended 1 September 2012. Highlights: Total revenue(£379.3m+4.3%) Operating Profit(£45.7m-2.8%) Profit before tax and fair value ...
Tags: N Brown Group, Half Year results, Total revenue, Profit before tax
Saffron Philippines Inc. (Saffron) has installed 8 sets Fong's Industries Group's TEC series within 8 months. The 4th shipment will be taken on or before end of 2012. Saffron Philippines Inc, one of dyeing and finishing, printing and ...
Tags: Market View, textile machine
Alere has presented positive results from PELICAN clinical trial,designed to assess the safety and efficacy of Triage placental growth factor (PlGF) blood test in diagnosing pre-eclampsia in women with suspected pre-eclampsia before 35 ...
Tags: PlGF Blood Test, placental growth factor blood test, PlGF testing